|
||||
|
||||
Diabetes Treatments and Moral Hazard
Jonathan Klick University of Pennsylvania Law School Thomas Stratmann George Mason University - Buchanan Center Political Economy; CESifo (Center for Economic Studies and Ifo Institute for Economic Research) FSU College of Law, Law and Economics Paper No. 05-21 FSU College of Law, Public Law Research Paper No. 159 Abstract: In the face of rising diabetes rates, many states passed laws requiring health insurance plans to cover medical treatments for the disease. Although supporters of the mandates expect them to improve the health of diabetics, they have the potential to generate a moral hazard to the extent that medical treatments might displace individual behavioral improvements. Another possibility is that the mandates do little to improve insurance coverage for most individuals, as previous research on benefit mandates has suggested that often mandates duplicate what plans already cover. To examine the effects of these mandates, we employ a triple differences methodology comparing the change in the gap in body mass index (BMI) between diabetics and non-diabetics in mandate and non-mandate states. We find that mandates do generate a moral hazard problem with diabetics exhibiting higher BMIs after the adoption of these mandates.
Keywords: Insurance, Mandates, Obesity, Offsetting Behavior JEL Classifications: I12, I18, J32, J38 Working Paper SeriesDate posted: July 23, 2005 ; Last revised: October 07, 2009Suggested CitationContact Information
|
|
||||||||||||||||||||||||
© 2009 Social Science Electronic Publishing, Inc. All Rights Reserved. Terms of Use Privacy Policy
This page was served by apollo2 in 0.109 seconds.